Back

Australian doctors publish positive meta–analysis on CardioQ–ODM™

21 November 2008 Deltex Medical Group plc ("Deltex Medical"), the UK's leading haemodynamic monitoring companyand global leader in oesophageal Doppler monitoring ("ODM"), announces today the publication of a further meta–analysis on ODM.

Doctors from St Vincent's Hospital in Melbourne have published their meta-analysis of ODM in the current issue of the Journal of the American College of Surgery. Their conclusions were that "using ODM to guide intraoperative IV fluid therapy will increase the administration of intraoperative IV colloid fluid and reduce length of hospital stay, time to resume full oral diet, and postoperative morbidity or complications".

The Company has this week received from its Australian distributor, Focus Medical, orders for ten CardioQ-ODM™ monitors and a standing order for 40 probes a month to meet the growing demand for ODM in Australia.

Deltex Medical's Chief Executive, Andy Hill commented:

"This is the third highly positive meta-analysis of ODM to be published in 2008 alone: the momentum behind establishing ODM as a standard of care during surgery is gathering pace in countries like Australia where our market development is still at an early stage."

For further information, please contact:

Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman: njk@deltexmedical.com
Andy Hill, Chief Executive: ahill@deltexmedical.com
Ewan Phillips, Finance Director: eap@deltexmedical.com

Gavin Anderson & Company 020 7554 1400
Deborah Walter: dwalter@gavinanderson.co.uk
Robert Speed: rspeed@gavinanderson.co.uk

Charles Stanley Securities 020 7149 6000
Nominated Advisor
Philip Davies: philip.davies@csysecurities.com
Russell Cook: russell.cook@csysecurities.com